Vision, international experience and strategic support to deliver impressive investment returns
Who we are
We are an international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare.
Our unique offering provides the opportunity to invest internationally, supported by the practical local knowledge and experience required to achieve success.
Our team
Our senior team has a diverse skill set, decades of international experience and proven success in healthcare investing and in the pharmaceutical industry.
We have completed over 170 investments and 40 IPO’s/reversals in North America, Europe and the Asia-Pacific region.
Investment approach
We invest in private and public healthcare companies with clear technological and market advantages in any territory, where we are confident that our engagement with management will deliver commercial success and returns for investors.
Impressive track record of success
Our track record of success is highly impressive, having consistently delivered annualised net IRR >20% (up to 40%) for the funds that we have managed.
International footprint
With offices in Melbourne, Australia and London, U.K. and senior management based in North America, Europe and the Asia-Pacific region, we have a strong international footprint.
In addition, our international network of advisors and experts in various other locations, including Sydney, Perth, Basel, Boston, Vancouver, Denver and Auckland, provide specialist assistance and support for our portfolio companies.
Ownership
BioScience Managers was founded in 2003 by Jeremy Curnock Cook, the former head of the Biosciences Unit at Rothschild Asset Management.
BioScience Managers Pty Ltd is a Corporate Authorised Representative of Phillip Asset Management Limited, part of the PhillipCapital Group, and operates under its Australian Financial Services License. PhillipCapital has offices operating in the financial hubs of 17 countries around the world providing access to valuable local knowledge, business contacts and funds to support the continuing growth of the BioScience Managers enterprise. Under management the assets of PhillipCapital total more than £30bn.